Combinations of nicotinic acetylcholine alpha 7 receptor agonists

Details for Australian Patent Application No. 2005300691 (hide)

Owner Novartis AG

Inventors Hurth, Konstanze; Gentsch, Conrad; Nozulak, Joachim; Vassout, Annick; Kalkman, Hans O.; Feuerbach, Dominik; Bilbe, Graeme

Agent Davies Collison Cave

Pub. Number AU-A-2005300691

PCT Pub. Number WO2006/048294

Priority 0424564.3 05.11.04 GB

Filing date 3 November 2005

Wipo publication date 11 May 2006

International Classifications

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/048294 Priority application(s): WO2006/048294

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005300692-Composition comprising VLP and amyloid-beta peptide

2005300688-Transcriptome microarray technology and methods of using the same